Corteva, Inc. $CTVA Shares Purchased by Swedbank AB

Key Points

• Swedbank AB raised its Corteva stake by 142.9%, buying an additional 1,117,021 shares to hold 1,898,735 shares (about 0.28% of the company) valued at roughly $127.3 million at quarter‑end.
• Corteva beat Q1 estimates with $1.50 EPS vs. ~$1.18 expected and $4.91B revenue (up ~11% YoY), and management reaffirmed FY‑2026 guidance of $3.45–3.70 EPS while saying the planned separation remains on track for Q4‑2026.
• The stock pulled back about 2.3% as the guidance midpoint sat slightly below some street expectations and investors took profits; analysts maintain a consensus "Moderate Buy" with an average target of $86.38.

Swedbank AB raised its stake in Corteva, Inc. (NYSE:CTVA - Free Report) by 142.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,898,735 shares of the company's stock after acquiring an additional 1,117,021 shares during the quarter. Swedbank AB owned approximately 0.28% of Corteva worth $127,272,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Reynders McVeigh Capital Management LLC boosted its stake in shares of Corteva by 2.9% during the 4th quarter. Reynders McVeigh Capital Management LLC now owns 5,686 shares of the company's stock worth $381,000 after purchasing an additional 160 shares during the last quarter. Fox Run Management L.L.C. grew its holdings in shares of Corteva by 5.1% during the third quarter. Fox Run Management L.L.C. now owns 3,361 shares of the company's stock worth $227,000 after buying an additional 164 shares in the last quarter. IFG Advisory LLC lifted its stake in shares of Corteva by 1.7% during the third quarter. IFG Advisory LLC now owns 9,764 shares of the company's stock valued at $660,000 after buying an additional 166 shares during the period. Kelleher Financial Advisors lifted its stake in shares of Corteva by 3.8% during the third quarter. Kelleher Financial Advisors now owns 4,594 shares of the company's stock valued at $311,000 after buying an additional 170 shares during the period. Finally, Rosenberg Matthew Hamilton lifted its stake in shares of Corteva by 6.1% during the fourth quarter. Rosenberg Matthew Hamilton now owns 2,969 shares of the company's stock valued at $199,000 after buying an additional 172 shares during the period. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Zacks Research cut shares of Corteva from a "strong-buy" rating to a "hold" rating in a research note on Friday, February 20th. Citigroup raised their price objective on Corteva from $74.00 to $80.00 and gave the stock a "neutral" rating in a report on Thursday, February 5th. Jefferies Financial Group lifted their price objective on Corteva from $85.00 to $95.00 and gave the company a "buy" rating in a research report on Monday, March 2nd. Argus upped their target price on Corteva from $80.00 to $91.00 and gave the company a "buy" rating in a research note on Tuesday, March 31st. Finally, Wolfe Research raised their price target on Corteva from $81.00 to $86.00 and gave the stock an "outperform" rating in a research note on Thursday, February 5th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average target price of $86.38.

Corteva Stock Down 2.3%

Shares of NYSE CTVA opened at $81.99 on Thursday. The stock has a market capitalization of $55.04 billion, a PE ratio of 48.23, a P/E/G ratio of 2.88 and a beta of 0.59. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The firm has a fifty day moving average of $80.66 and a 200-day moving average of $72.48. Corteva, Inc. has a 52-week low of $60.53 and a 52-week high of $85.63.

Corteva (NYSE:CTVA - Get Free Report) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a return on equity of 9.88% and a net margin of 6.50%.The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same period last year, the company posted $1.13 EPS. The business's quarterly revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, analysts anticipate that Corteva, Inc. will post 3.62 EPS for the current year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Stockholders of record on Monday, June 1st will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, June 1st. Corteva's dividend payout ratio (DPR) is 45.57%.

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 8,311 shares of Corteva stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider directly owned 8,090 shares of the company's stock, valued at $619,289.50. The trade was a 50.67% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. 0.15% of the stock is owned by corporate insiders.

Trending Headlines about Corteva

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Q1 beat — Corteva reported $1.50 EPS vs. ~$1.18 consensus and revenue of $4.91B (up ~11% YoY), driven by stronger sales across its Seed and Crop Protection portfolios. This was the main catalyst for initial bullishness after the print. Corteva, Inc. (CTVA) Beats Q1 Earnings and Revenue Estimates
• Positive Sentiment: Business momentum — Management highlighted continued strength in Seed and Crop Protection technologies and progress on growth platforms, plus productivity/cost initiatives that are improving the company’s financial profile. This supports medium‑term margin and cash‑flow improvement expectations. Corteva Delivers Strong 1Q 2026, Reaffirms 2026 Outlook, On-Track for 4Q 2026 Separation
• Positive Sentiment: Planned separation on track — Management reiterated that the planned separation (targeted for 4Q 2026) remains on schedule; investors often view an on‑track separation as potential value unlocking. Corteva Agriscience: Corteva Delivers Strong 1Q 2026, Reaffirms 2026 Outlook, On-Track for 4Q 2026 Separation
• Neutral Sentiment: Guidance reaffirmed — The company reaffirmed FY‑2026 EPS guidance at $3.450–3.700, signaling management sees the beat as consistent with earlier expectations; that removes downside surprise risk but does not materially raise the bar. Corteva Delivers Strong 1Q 2026, Reaffirms 2026 Outlook, On-Track for 4Q 2026 Separation
• Neutral Sentiment: Call color — Transcripts show management focused on execution, margin expansion and separation planning; there were no major changes to capital allocation or a materially raised FY outlook on the call. Read the full call transcript for management tone and Q&A. Corteva, Inc. (CTVA) Q1 2026 Earnings Call Transcript
• Negative Sentiment: Guidance vs. street — The reaffirmed FY range’s midpoint sits slightly below some street expectations (consensus ~3.65), so while management didn’t cut guidance, the lack of an upward revision likely disappointed some investors and pressured the stock. Compared to Estimates, Corteva, Inc. (CTVA) Q1 Earnings: A Look at Key Metrics
• Negative Sentiment: Profit‑taking / valuation — After a solid quarter and a run toward the 12‑month high, the stock is pulling back as investors lock in gains; valuation metrics (e.g., a relatively high P/E) may amplify the downside on a cautious guidance reaction. Corteva (CTVA) Q1 2026 Earnings Transcript

Corteva Company Profile

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.